Oppenheimer Reiterates Outperform on Exelixis, Maintains $25 Price Target
Portfolio Pulse from richadhand@benzinga.com
Oppenheimer analyst Jay Olson has reiterated an 'Outperform' rating on Exelixis (NASDAQ:EXEL) and maintained a $25 price target.
July 31, 2023 | 1:42 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Oppenheimer analyst Jay Olson has reiterated an 'Outperform' rating on Exelixis and maintained a $25 price target.
The reiteration of an 'Outperform' rating by Oppenheimer analyst Jay Olson indicates a positive outlook for Exelixis. The maintained price target of $25 suggests that the analyst believes the stock has potential for growth. This could lead to increased investor confidence and potentially a rise in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100